Anlon Healthcare acquires 67.48% stake in Apiqo Organics

09 Jan 2026 Evaluate

Anlon Healthcare has completed the acquisition of 67.48% equity shareholding of Apiqo Organics on January 9, 2026. Consequent to this acquisition, Apiqo Organics has become a subsidiary of the company. The acquisition of the Apiqo Organics will significantly enhances the company’s vertical integration, secures critical supply of high-quality intermediates, increases additional 700 to 800 MT annual manufacturing capacity for advanced pharmaceutical intermediates, and strengthens the ability of the company to deliver reliable, cost-effective solutions to its global pharmaceutical partners.

Earlier, the company had entered into a Share Purchase Agreement (SPA) with Apiqo Organics (formerly known as M/s Apple Life Science, a partnership firm) for the same.

Anlon Healthcare is a chemical manufacturing company engaged in manufacturing of pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs), which are supplied to customers both in India and international markets.

Anlon Healthcare Share Price

143.35 -0.30 (-0.21%)
09-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.95
Dr. Reddys Lab 1209.45
Cipla 1466.15
Zydus Lifesciences 894.95
Lupin 2181.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×